Market closed

Xtant Medical/$XTNT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Xtant Medical

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Ticker

$XTNT
Sector
Health Care

Trading on

AMEX

Industry

Health Care Equipment & Supplies
Headquarters
Belgrade, United States

Employees

211
Website
www.xtantmedical.com

Xtant Medical Metrics

BasicAdvanced
$70M
-
-$0.13
0.38
-

$70M

0.38

$1.30

$0.33

164K

2.121

0.806

42.537

78.622

-3.64%

-9.17%

-35.03%

0.585

1.54

2.37

-3.854

45.11%

-687.70%

27.21%

48.58%

What the Analysts think about Xtant Medical

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Xtant Medical stock.

Xtant Medical Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Xtant Medical Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Xtant Medical News

AllArticlesVideos
Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript

Seeking Alpha·2 months ago
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

Accesswire·2 months ago
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XTNT

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Xtant Medical stock?

Xtant Medical (XTNT) has a market cap of $70M as of January 15, 2025.

What is the P/E ratio for Xtant Medical stock?

The price to earnings (P/E) ratio for Xtant Medical (XTNT) stock is 0 as of January 15, 2025.

Does Xtant Medical stock pay dividends?

No, Xtant Medical (XTNT) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Xtant Medical dividend payment date?

Xtant Medical (XTNT) stock does not pay dividends to its shareholders.

What is the beta indicator for Xtant Medical?

Xtant Medical (XTNT) has a beta rating of 0.38. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.